Palisadebio
Founded 2005 · 25 employees on LinkedIn · 1 known investors
Palisade Bio is a clinical-stage biopharmaceutical company developing therapies for autoimmune and inflammatory diseases, including its lead candidate PALI-2108, based on a PDE4 prodrug platform.
Investors · 1
Frequently asked questions
- What does Palisadebio do?
- Palisade Bio is a clinical-stage biopharmaceutical company developing therapies for autoimmune and inflammatory diseases, including its lead candidate PALI-2108, based on a PDE4 prodrug platform.
- Who are Palisadebio's investors?
- Palisadebio's investors include Altium Capital.